Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non‐hypertensive Alzheimer's patients

Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non‐hypertensive Alzheimer's patients

Abstract Introduction Acetylcholinesterase inhibitors (AChEIs) are commonly used to treat mild to moderate cases of Alzheimer disease (AD). To the best of our knowledge, there has been no study estimating the risk of bleeding and cardiovascular events in patients with non‐hypertensive AD. Therefore,...

Full description

Bibliographic Details
Main Authors: Faez Saleh Al‐Hamed, Stamatis Kouniaris, Iskandar Tamimi, Marie Lordkipanidzé, Sreenath Arekunnath Madathil, Abbas Kezouh, Igor Karp, Belinda Nicolau, Faleh Tamimi
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
acetylcholinesterase inhibitors
aging
Alzheimer's disease
bleeding
cardiovascular disease
stroke
Online Access:https://doi.org/10.1002/trc2.12184

Internet

https://doi.org/10.1002/trc2.12184

Similar Items